From:
To:
Subject: RE: Epstein Briefing Follow-up
Date: Tue, 20 Oct 2020 13:41:53 +0000
Importance: Normal
I have 1pm. I'll send out the conference line.
From:
Sent: Tuesday, October 20, 2020 9:41 AM
To:
Subject: (EXTERNAL EMAIL) - RE: Epstein Briefing Follow-up
Hi all,
I am sorry I cannot recall if we settled a time but I am free most of the day, except for 10-10:30 and 12-1.
Thank you,
From:
Sent: Monday, October 19, 2020 5:39 PM
To:
Subject: RE: Epstein Briefing Follow-up
Good afternoon,
I am awaiting clearance from other DOJ components on the November 12 date. I have attached a draft of
the invitation/RSVP with preliminary comments. We can discuss these tomorrow.
Thanks
From:
Sent: Monday, October 19, 2020 3:14 PM
To:
Subject: Re: Epstein Briefing Follow-up
Hello,
EFTA00038022
Hope everyone is doing well. Checking in to see if there are any updates regarding the November 12 date as well as a draft
for the invitation?
Thanks!
Program Manager
FBI Victim Services Division
From:
Sent: Friday, October 16, 2020 2:45 PM
To: >;
Subject: Epstein Briefing Follow-up
Hello,
Following up on today's phone call on a few things:
• The Miami FO has the All-Employee Conference Room is available for November 5 and 12 (November 11is
Veteran's Day).
• Suggestions for invitation:
o Clear identification of the briefing purpose;
o Date, location of briefing (Time TBD);
o Inclusion of support person language;
o COVID precautions (see below);
o RSVD deadline; and
o Request any questions from victims in advance and have them send by a certain date.
• Please find attached a few documents from our briefing last fall:
o RSVP Questionnaire Blank
o Template Letter for 2019 briefings
o Name tag key
• Miami COVID procedures to enter the building (see attached documents)
o Temperature checks
o CDC screening questions
o Social distancing
o Mandatory face masks
Please let me know the confirmed date ASAP so I can begin my canvass of the field for Victim Specialists to assist in
Miami. I look forward to seeing your DRAFT invitation letter.
Thanks,
EFTA00038023
EFTA00038024